Compare VS & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VS | BFRG |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3M | 10.7M |
| IPO Year | 2017 | 2022 |
| Metric | VS | BFRG |
|---|---|---|
| Price | $1.31 | $0.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.9K | ★ 132.3K |
| Earning Date | 04-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.97 | 25.88 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,183,415.00 | $116,670.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3711.30 | 79.49 |
| 52 Week Low | $0.75 | $0.43 |
| 52 Week High | $2.72 | $2.04 |
| Indicator | VS | BFRG |
|---|---|---|
| Relative Strength Index (RSI) | 47.86 | 45.94 |
| Support Level | $1.19 | $0.59 |
| Resistance Level | $1.74 | $0.69 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 39.26 | 58.33 |
Versus Systems Inc operates within the technology sector, focusing on engagement-enhancing solutions through its proprietary prizing and promotions platform. This technology enables developers and content creators across streaming, live events, broadcast, gaming, and other media to integrate real-world prizes into their experiences, fostering greater consumer interaction and providing a compelling opportunity for brand partners and advertisers. The company operates in Canada and the USA.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development.